The MMPE technology uses synergistic combinations of certain specific pharmaceutical excipients included on the FDA’s Inactive Ingredients Database (“IID”) for improved topical delivery of active ingredients into or through the skin.
Drug-containing cream/gel applied to a patient's skin forming pliable layer that releases drug into the skin for up to 12 hours.
Proven compatibility with a variety of active ingredients.
Self-occluding film reduces product transference risk.
Fast drying time and easy application & removal.
Effective application to large and irregular skin surfaces.
Patents issued in Australia, Canada, China, Japan and the United States with the latest expiry in 2027.
Patent application pending in Europe.